Matinas BioPharma
MTNB
#10245
Rank
NZ$5.37 M
Marketcap
$1.06
Share price
-6.03%
Change (1 day)
-93.17%
Change (1 year)

Earnings for Matinas BioPharma (MTNB)

Earnings in 2024 (TTM): -NZ$40.98 Million

According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$38.52 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Matinas BioPharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$40.86 Million6.05%
2023 -NZ$38.52 Million9.26%
2022 -NZ$35.26 Million-9.82%
2021 -NZ$39.1 Million3.73%
2020 -NZ$37.69 Million29.21%
2019 -NZ$29.17 Million19.07%
2018 -NZ$24.5 Million-7.91%
2017 -NZ$26.61 Million108.5%
2016 -NZ$12.76 Million-16.82%
2015 -NZ$15.34 Million-10.62%
2014 -NZ$17.17 Million175.27%
2013 -NZ$6.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 487.30%๐Ÿ‡บ๐Ÿ‡ธ USA